Innovator Spotlight: Innovation Through Partnerships Is In Omron Healthcare's Blood

This year, Omron Healthcare launched its new HeartGuide smartwatch and the first FDA-cleared blood pressure monitor with EKG capability. Medtech Insight sat down with Omron's CEO Ranndy Kellogg to learn about upcoming plans.

Heartbeat and Heart rate line concept on white background. Vector illustration. - Vector

This has been a big year for Omron Healthcare Inc. In January, the maker of blood pressure monitoring systems launched its HeartGuide smartwatch, which measures blood pressure through the wrist. In May, it started selling the first US Food and Drug Administration-cleared at-home blood pressure monitor with EKG capability, called Complete, on the company website as well as in major online retail stores such Amazon and BestBuy.

More from Digital Technologies

‘Profitability On The Horizon’ For UV-C Disinfection Solution Company Germitec

 

France-based Germitec aims to double its yearly revenue by expanding its UV-C disinfection technology for endocavitary ultrasound probes into the US market.

PathAI Enters South American Market Partnering With Integrated Healthcare Network Rede D’or

 

PathAI, a Boston-based AI-pathology startup backed by $355m, partners with Brazil’s largest integrated healthcare network to support diagnosis and treatment of cancer patients using its AISight image management system.

More Patients Free From Atrial Fibrillation With AI-Guided Pulmonary Vein Isolation Treatment

 

Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.

LinusBio Launches Diagnostic Tool To Support Earlier Diagnosis Of Autism In Children

 

Precision medicine startup LinusBio launches its breakthrough diagnostic aid across 44 US states. The laboratory test aims to support earlier diagnosis of autism spectrum disorder and can be ordered by health care providers.

More from Medtech Insight

More Patients Free From Atrial Fibrillation With AI-Guided Pulmonary Vein Isolation Treatment

 

Volta Medical’s TAILORED-AF clinical trial demonstrates that AI can achieve "superior efficacy" in interventional cardiology. The study examined the use of AI-driven Volta AF-Xplorer in addition to pulmonary vein isolation in treating patient with persistent atrial fibrillation.

FDA Guidance Docs On Trial Diversity, Sex Differences Restored After Court Order

 
• By 

A federal judge granted Doctors for America’s motion for a temporary restraining order directing the FDA and CDC to restore information removed from the agencies’ websites to comply with a presidential executive order targeting “gender ideology extremism.”

What’s The Scope Of Endoscope Risk?

 

For the fourth time in as many years the FDA has issued a communication concerning a key accessory from Olympus used in several types of urological procedures. This time, however, the agency has added a class I recall confirmation to its original early alert on the device issued in December 2024. A device safety specialist provided Medtech Insight with a deeper understanding of the problem as well as overall scope safety.